
iSERA Lifesciences Ltd is Rated Sell
2026-08-21 10:10:24iSERA Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Covidh Technologies Ltd is Rated Sell
2026-08-10 10:10:03Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Covidh Technologies Ltd Reports Flat Financial Trend Amid Mixed Quarterly Performance
2026-08-10 08:00:06Covidh Technologies Ltd, a micro-cap stock, has experienced a notable shift in its financial trend, moving from positive growth to a flat trajectory in the latest quarter ending June 2026. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s earnings before depreciation, interest and taxes (PBDIT) and profit before tax excluding other income (PBT less OI) have deteriorated to their lowest quarterly levels, signalling challenges ahead for investors.
Read full news article
Covidh Technologies Ltd is Rated Sell
2026-07-30 10:10:03Covidh Technologies Ltd is rated Sell by MarketsMOJO. This rating was last updated on 03 Jul 2025, but the analysis below reflects the stock’s current position as of 30 July 2026, incorporating the latest fundamentals, returns, and financial metrics available today.
Read full news article
Covidh Technologies Ltd is Rated Sell
2026-07-19 10:10:03Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, a rating that was established on 03 Jul 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Covidh Technologies Ltd is Rated Sell
2026-07-08 10:10:04Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Broad-Based Technical Strength Lifts Covidh Technologies Ltd to 52-Week High of Rs 142.45
2026-07-07 11:40:05Surging past Rs 142.45 on 7 Jul 2026, Covidh Technologies Ltd has marked a significant milestone by reaching a fresh 52-week high, propelled by a sustained 21-day winning streak and a remarkable 51.27% return over this period.
Read full news article
Broad-Based Technical Strength Lifts Covidh Technologies Ltd to 52-Week High of Rs 139.7
2026-07-06 10:36:02Surging to a new 52-week high of Rs 139.7 on 6 Jul 2026, Covidh Technologies Ltd has demonstrated remarkable price momentum, climbing steadily for 21 consecutive sessions and delivering a 55.76% return over this period. This rally stands out amid a broadly rising Sensex, which itself has gained 3.54% over the past three weeks.
Read full news articleSubmission Of Monitoring Agency Report For Utilization Of Proceeds Of Rights Issue Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) For The Quarter Ended June 30 2026.
14-Aug-2026 | Source : BSEWe hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended June 30 2026.
Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.08.2026 Under Regulation 30 Of SEBI
07-Aug-2026 | Source : BSEUn-Audited Financial Results For The Quarter Ended June 30 2026
07-Aug-2026 | Source : BSEWe are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
Corporate Actions
No Upcoming Board Meetings
iSERA Lifesciences Ltd has declared 5% dividend, ex-date: 20 Sep 13
No Splits history available
No Bonus history available
iSERA Lifesciences Ltd has announced 25:1 rights issue, ex-date: 24 Oct 25







